Nathan L. Mata - 01 May 2026 Form 4 Insider Report for BELITE BIO, INC (BLTE)

Reporting relationship: Chief Scientific Officer
Issuer ticker: BLTE
Reported as of: 01 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 May 2026, 16:15:07 UTC
Source filing: View source filing
Reporting owner signature: /s/ Nathan L. Mata

Key filing fact

Nathan L. Mata filed Form 4 for BELITE BIO, INC (BLTE) on 04 May 2026.

Key facts

This page summarizes Nathan L. Mata's Form 4 filing for BELITE BIO, INC (BLTE).
8 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 04 May 2026, 16:15.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002013987 Primary reporting owner

MATA NATHAN L.

Relationship: Chief Scientific Officer
Address: 7708 MARKER ROAD, SAN DIEGO
Signature: /s/ Nathan L. Mata
Signature date: 04 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BLTE transaction

American depositary share

Sale

Transaction value
Shares: -52
Change %: -1.1%
Price: $153.89^*
Shares after: 4,614
Date: 01 May 2026
Ownership: Direct
Footnotes: F1, F2, F3

BLTE transaction

American depositary share

Sale

Transaction value
Shares: -288
Change %: -6.2%
Price: $154.38^*
Shares after: 4,326
Date: 01 May 2026
Ownership: Direct
Footnotes: F1, F2, F4

BLTE transaction

American depositary share

Sale

Transaction value
Shares: -346
Change %: -8%
Price: $155.48^*
Shares after: 3,980
Date: 01 May 2026
Ownership: Direct
Footnotes: F1, F2, F5

BLTE transaction

American depositary share

Sale

Transaction value
Shares: -82
Change %: -2.1%
Price: $156.24^*
Shares after: 3,898
Date: 01 May 2026
Ownership: Direct
Footnotes: F1, F2, F6

BLTE transaction

American depositary share

Sale

Transaction value
Shares: -106
Change %: -2.7%
Price: $157.45^*
Shares after: 3,792
Date: 01 May 2026
Ownership: Direct
Footnotes: F1, F2, F7

BLTE transaction

American depositary share

Sale

Transaction value
Shares: -65
Change %: -1.7%
Price: $158.35^*
Shares after: 3,727
Date: 01 May 2026
Ownership: Direct
Footnotes: F1, F2, F8

BLTE transaction

American depositary share

Sale

Transaction value
Shares: -38
Change %: -1%
Price: $159.08^*
Shares after: 3,689
Date: 01 May 2026
Ownership: Direct
Footnotes: F1, F2, F9

BLTE transaction

American depositary share

Sale

Transaction value
Shares: -23
Change %: -0.62%
Price: $160.00^*
Shares after: 3,666
Date: 01 May 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 9 footnotes

Footnote F1

Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer.

Footnote F2

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025.

Footnote F3

Represents the weighted average price of shares sold at prices that ranged from $153.8 to $153.98. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.

Footnote F4

Represents the weighted average price of shares sold at prices that ranged from $154 to $154.86. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.

Footnote F5

Represents the weighted average price of shares sold at prices that ranged from $155 to $155.98. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.

Footnote F6

Represents the weighted average price of shares sold at prices that ranged from $156 to $156.97. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.

Footnote F7

Represents the weighted average price of shares sold at prices that ranged from $157.15 to $157.9. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.

Footnote F8

Represents the weighted average price of shares sold at prices that ranged from $158 to $158.93. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.

Footnote F9

Represents the weighted average price of shares sold at prices that ranged from $159 to $159.47. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.